Insmed Inc. buy Royal Bank of Canada
Start price
19.03.25
/
50%
€71.50
Target price
19.03.26
€91.44
Performance (%)
73.43%
End price
20.03.26
€124.00
Summary
This prediction ended on 20.03.26 with a price of €124.00. The BUY prediction by Royal_Bank_of_Canada for Insmed Inc. saw massive gains of 73.43%. Royal_Bank_of_Canada has a follow-up prediction for Insmed Inc. where he still thinks Insmed Inc. is a Buy. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Insmed Inc. | -6.721% | -6.721% | 94.317% |
| iShares Core DAX® | 3.593% | 6.427% | 15.378% |
| iShares Nasdaq 100 | 5.810% | 6.381% | 41.455% |
| iShares Nikkei 225® | 4.075% | 9.307% | 48.947% |
| iShares S&P 500 | 4.142% | 4.938% | 31.594% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Insmed Inc. diskutieren
Insmed Incorporated (NASDAQ: INSM) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $100.00 price target on the stock.
Ratings data for INSM provided by MarketBeat
In the thread Trading Insmed Inc.
Die von Royal_Bank_of_Canada gewählte maximale Laufzeit wurde überschritten